-
Here’s how young Native Americans responded when Newman’s Own and Novo Nordisk let them grant $720K
19 Oct 2025 12:21 GMT
-
Stocks to Watch Recap: American Express, Zions, Novo Nordisk
19 Oct 2025 03:44 GMT
↗️ American Express (AXP): The credit-card company reported a jump in profit and revenue, as cardholders spent more and card fees grew. Shares advanced 7.3%. ↗️ Zions Bancorp (ZION), Western Alliance Bancorp (WAL): Shares in the two lenders rose 5.
-
These Stocks Moved the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More
19 Oct 2025 02:54 GMT
-
Weekly Stock Market Update: Apple, Taiwan Semiconductor and Novo Nordisk
19 Oct 2025 00:39 GMT
It was a volatile but ultimately positive week on Wall Street, marked by renewed tensions in the U.S.-China trade war and a strong start to the earnings season. Major banks exceeded expectations, while regional lenders expressed concern over delinquencies, …
-
Novo Nordisk GLP-1 pill now U.S. approved for heart disease risk
18 Oct 2025 18:27 GMT
JHVEPhoto/iStock Editorial via Getty ImagesNovo Nordisk (NVO) has received approval to market its oral GLP-1 medicine Rybelsus in the U.S. to reduce the risk of major cardiovascular events such as stroke in adults with type 2 diabetes, the Danish …
-
Novo Nordisk and Ebn Sina Medical host second ACT Summit in Qatar
18 Oct 2025 17:05 GMT
Novo Nordisk Qatar, under Ebn Sina … held in Dubai in May, Novo Nordisk Qatar, under Ebn Sina … General Manager, Novo Nordisk Qatar, stated:
“ACT Summit reinforces Novo Nordisk’s commitment to … with leading global innovators like Novo Nordisk.
“The ACT Summit 2 …
-
FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
17 Oct 2025 23:26 GMT
… Wegovy® including Medication Guide.
About Novo Nordisk
Novo Nordisk is a leading global healthcare … .
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2025 Novo Nordisk All …
-
Novo Nordisk Acquires Rights to Zaltenibart in $2.1B Rare Disease Deal with Omeros
17 Oct 2025 18:28 GMT
… into a definitive agreement granting Novo Nordisk exclusive global rights to … regulatory approvals.
“This agreement enables Novo Nordisk to strengthen its Rare Disease … Demopulos, M.D., added, “With Novo Nordisk driving zaltenibart forward, Omeros will …
-
Novo Nordisk Stock Is Falling Friday: What's Driving The Action?
17 Oct 2025 17:46 GMT
Shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE … price.
What To Know: Novo Nordisk is the manufacturer of Ozempic … prices creates significant risk for Novo Nordisk’s bottom line. Investors … instrument.
For example, in Novo Nordisk’s case, it is …
-
Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts
17 Oct 2025 16:28 GMT
… Jacobsen
LONDON/COPENHAGEN (Reuters) -Novo Nordisk has appointed U.S. pharmaceutical … on LinkedIn on Friday and Novo Nordisk shared the statement with Reuters …